| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.21 | 6e-05 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.21 | 9e-05 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.0007 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.21 | 0.002 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.004 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.006 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.007 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.009 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.01 |